Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain.

PURPOSE To investigate whether diffusion-weighted and magnetization transfer (MT) magnetic resonance (MR) imaging depict regional and/or global brain abnormalities in patients with Huntington disease (HD). MATERIALS AND METHODS Twenty-one carriers of the HD mutation (mean age, 58 years +/- 11 [SD]) and 21 healthy control subjects (mean age, 54 years +/- 13) underwent conventional, diffusion-weighted, and MT MR imaging. Volumes, mean apparent diffusion coefficients (ADCs), and MT ratios (MTRs) for left and right caudate nucleus, putamen, and cerebral periventricular white matter-as well as an index of normalized brain volume and whole-brain ADC and MT histograms-were computed. Asymmetry in volume, ADC, and MTR measurements in caudate nucleus, putamen, and periventricular white matter in control subjects and HD carriers were evaluated with Wilcoxon testing for paired samples. Differences in MR imaging variables between HD carriers and control subjects were evaluated with Mann-Whitney U testing; correlations between stages of clinical severity and MR imaging data were investigated with Spearman rank correlation testing. RESULTS No significant asymmetry was observed for any of the MR imaging variables. Caudate nucleus, putamen, and whole-brain volumes were smaller (P <.001 for all) in HD carriers than in control subjects. HD carriers also had increased ADC in the caudate nucleus (P =.002), putamen (P <. 001), cerebral periventricular white matter (P <.001), and whole brain (P <.001). MTR was not significantly different between HD carriers and control subjects. Correlation was observed between stages of increasing clinical disease severity and both decrease in volume of caudate nucleus (Spearman rho = -0.63), putamen (rho = -0.64), and whole brain (rho = -0.46) and increase in ADC in caudate nucleus (rho = 0.52), periventricular white matter (rho = 0.45), and whole brain (rho = 0.44). CONCLUSION Regional and global volume loss in HD is accompanied by an increase in ADC; this correlates with disease severity.

[1]  Jack L Lancaster,et al.  MR imaging volumetry of subcortical structures and cerebellar hemispheres in normal persons. , 2003, AJNR. American journal of neuroradiology.

[2]  M Takasaki,et al.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia. , 2000, AJNR. American journal of neuroradiology.

[3]  M. Rovaris,et al.  Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy , 2001, Journal of neurology, neurosurgery, and psychiatry.

[4]  V. Sossi,et al.  Bilateral human fetal striatal transplantation in Huntington’s disease , 2002, Neurology.

[5]  A. Gass,et al.  Acute and chronic changes of the apparent diffusion coefficient in neurological disorders—biophysical mechanisms and possible underlying histopathology , 2001, Journal of the Neurological Sciences.

[6]  M. Filippi,et al.  Magnetization transfer and diffusion-weighted imaging in nocturnal frontal lobe epilepsy , 2000, Neurology.

[7]  M. Kaste,et al.  Diffusion-weighted MR imaging in normal human brains in various age groups. , 2002, AJNR. American journal of neuroradiology.

[8]  S. Fahn,et al.  Huntington disease , 1979, Neurology.

[9]  Mario Mascalchi,et al.  Whole brain apparent diffusion coefficient histogram: A new tool for evaluation of leukoaraiosis , 2002, Journal of magnetic resonance imaging : JMRI.

[10]  G. Pearlson,et al.  Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[11]  C D Good,et al.  The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.

[12]  I. Shoulson,et al.  Huntington disease , 1981, Neurology.

[13]  P S Harper,et al.  Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. , 1996, American journal of human genetics.

[14]  G. Comi,et al.  Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI , 2000, Neurology.

[15]  C. Rorden,et al.  Stereotaxic display of brain lesions. , 2000, Behavioural neurology.

[16]  D. Shibata,et al.  MR volumetric analysis of the human basal ganglia: normative data. , 2000, Academic radiology.

[17]  S. Folstein,et al.  Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease , 1992, Annals of neurology.

[18]  G. Scotti,et al.  Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI , 2001, Neurology.

[19]  D. DeLong,et al.  The effect of aging on the apparent diffusion coefficient of normal-appearing white matter. , 2000, AJR. American journal of roentgenology.

[20]  J. Wuu,et al.  Huntington’s disease: A randomized, controlled trial using the NMDA-antagonist amantadine , 2002, Neurology.

[21]  K. Sieradzan,et al.  The selective vulnerability of nerve cells in Huntington's disease , 2001, Neuropathology and applied neurobiology.

[22]  A. Uluğ,et al.  Diffusion changes in the aging human brain. , 2000, AJNR. American journal of neuroradiology.

[23]  N Makris,et al.  Striatal volume loss in HD as measured by MRI and the influence of CAG repeat , 2001, Neurology.

[24]  B S Peterson,et al.  Human basal ganglia volume asymmetries on magnetic resonance images. , 1993, Magnetic resonance imaging.

[25]  C. Grandinetti,et al.  Nonisotopic method for accurate detection of (CAG)n repeats causing Huntington disease. , 1996, Clinical chemistry.

[26]  R. Adams,et al.  Principles of Neurology , 1996 .

[27]  M S Buchsbaum,et al.  Regional and global changes in cerebral diffusion with normal aging. , 2001, AJNR. American journal of neuroradiology.

[28]  H. Hanyu,et al.  Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy , 2001, Neuroradiology.

[29]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[30]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[31]  A. Dale,et al.  Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.

[32]  J. Brandt,et al.  Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk persons , 1994, Neurology.

[33]  Christopher A Ross,et al.  Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.

[34]  J. B. Martin,et al.  Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.

[35]  H. Hanyu,et al.  Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease , 1998, Journal of the Neurological Sciences.

[36]  S. Rose,et al.  Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.

[37]  M. Filippi,et al.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[38]  Faith M. Gunning-Dixon,et al.  Differential aging of the human striatum: a prospective MR imaging study. , 1998, AJNR. American journal of neuroradiology.

[39]  T Hindmarsh,et al.  Diffusion tensor trace mapping in normal adult brain using single-shot EPI technique. A methodological study of the aging brain. , 2001, Acta radiologica.